These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors. Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256 [TBL] [Abstract][Full Text] [Related]
3. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614 [TBL] [Abstract][Full Text] [Related]
4. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors. Candido Dos Reis F; Moreira de Andrade J; Bighetti S Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433 [TBL] [Abstract][Full Text] [Related]
5. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary. Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823 [TBL] [Abstract][Full Text] [Related]
6. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors? Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245 [TBL] [Abstract][Full Text] [Related]
7. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Foekens JA; Peters HA; Grebenchtchikov N; Look MP; Meijer-van Gelder ME; Geurts-Moespot A; van der Kwast TH; Sweep CG; Klijn JG Cancer Res; 2001 Jul; 61(14):5407-14. PubMed ID: 11454684 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150 [TBL] [Abstract][Full Text] [Related]
9. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts. Sundfeldt K; Ivarsson K; Rask K; Haeger M; Hedin L; Brännström M Anticancer Res; 2001; 21(1A):65-70. PubMed ID: 11299791 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Lutgendorf SK; Johnsen EL; Cooper B; Anderson B; Sorosky JI; Buller RE; Sood AK Cancer; 2002 Aug; 95(4):808-15. PubMed ID: 12209725 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of serum VEGF in women with ovarian tumors. Oehler MK; Caffier H Anticancer Res; 1999; 19(4A):2519-22. PubMed ID: 10470186 [TBL] [Abstract][Full Text] [Related]
12. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC. Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676 [TBL] [Abstract][Full Text] [Related]
13. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes. Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286 [TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors]. Peng XP; Li JD; Li MD; Ye XM; Yan WC Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072 [TBL] [Abstract][Full Text] [Related]
15. [Expression of vascular endothelial growth factor and microvessel density in ovarian tumor]. Qi SY Ai Zheng; 2003 Mar; 22(3):320-3. PubMed ID: 12654197 [TBL] [Abstract][Full Text] [Related]
16. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis. Nagashima M; Asano G; Yoshino S J Rheumatol; 2000 Oct; 27(10):2339-42. PubMed ID: 11036826 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma. Shen GH; Ghazizadeh M; Kawanami O; Shimizu H; Jin E; Araki T; Sugisaki Y Br J Cancer; 2000 Jul; 83(2):196-203. PubMed ID: 10901370 [TBL] [Abstract][Full Text] [Related]
18. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood. Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925 [TBL] [Abstract][Full Text] [Related]
19. Angiogenic protein expression in advanced epithelial ovarian cancer. Barton DP; Cai A; Wendt K; Young M; Gamero A; De Cesare S Clin Cancer Res; 1997 Sep; 3(9):1579-86. PubMed ID: 9815846 [TBL] [Abstract][Full Text] [Related]
20. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma. Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]